Gunjan Shah

67PUBLICATIONS
280CO-AUTHORS
Haematological tumoursCarbon capture engineering (excl. sequestration)Predictive and prognostic markersMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

|Nov 04, 2026
Impact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma.

|Oct 20, 2026
The EF1α promoter of cilta-cel drives a highly effective GZMK+ transcriptional program.

|Oct 02, 2026
Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial.

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes after CD19 CAR T-cell Therapy in Large B-cell Lymphoma.

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma Is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

Pageof 12

Frequent Collaborators

38 joint publications

Sergio Giralt

27 joint publications

Heather Landau

24 joint publications

Urvi Shah

23 joint publications

Sham Mailankody